Clinical trial Recruiting at 1 site Observational Ages 18 and up

Ultrasound screening and combined treatment strategies for people with coronary and neck artery narrowing.

Official title: A Real-World Study on Ultrasound-Based Screening and Integrated Therapeutic Strategies for Patients With Concomitant Coronary and Cervicocephalic Artery Stenosis

Run by Beijing Anzhen Hospital · NCT07034157 · Data updated 2026-11-12

This project uses Doppler ultrasound to screen people with coronary artery disease scheduled for elective PCI to see if finding and managing neck artery narrowings together with heart procedures leads to better outcomes.

More Coronary Artery Disease trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment1000 (estimated)
SponsorBeijing Anzhen Hospital
Academic / other
Locations1 site (Beijing)
StatusRecruiting
StartedJune 9, 2025
Main results expectedJanuary 30, 2026
Study endsDecember 30, 2026
Registry record updatedJune 24, 2025
Trial IDNCT07034157 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 and older with coronary artery disease who are scheduled for elective percutaneous coronary intervention and expected to survive at least one year are ideal candidates.

Probably not a fit

People who are not having PCI, have an expected survival under one year, or have other serious concurrent illnesses are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective observational cohort enrolling adults with coronary artery disease who are scheduled for elective percutaneous coronary intervention at Beijing Anzhen Hospital. Participants receive Doppler ultrasound screening of head and neck arteries the day before PCI to document any cervicocephalic arterial stenosis and its severity. The study records which management approach is used—observation, cerebrovascular intervention such as carotid stenting, or combined procedures—and tracks clinical outcomes including stroke, cardiac events, and death. Data will provide real-world information on the prevalence of concurrent stenosis and the associations between different integrated treatment strategies and patient outcomes.

Why it matters

Potential benefit: If successful, the findings could help doctors spot and treat dangerous neck artery narrowings in people having PCI, potentially reducing stroke and other complications.

How similar studies have gone: Previous observational studies and limited interventional research have linked carotid and coronary disease and suggest potential benefit from combined care, but randomized evidence on integrated screening-and-treatment pathways remains limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age ≥18 years;
2. Patients with coronary artery disease scheduled to undergo elective percutaneous coronary intervention (PCI) on the following day.

Exclusion Criteria:

1. The expected survival is less than 1 years;
2. Simultaneously merge other serious diseases;

Where it's running

  • Beijing Anzhen Hospital
    Beijing, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.